Posting of Circular and Notice of General Meeting
Futura Medical plc has announced the posting of a Circular and Notice of General Meeting to shareholders, following up on a previous announcement regarding a Fundraise. The General Meeting is scheduled to take place on September 23, 2026, at 10:00 a.m. at Panmure Liberum's offices in London. The company will announce the results of the voting on all resolutions via RNS and publish the full voting results on its website after the meeting concludes.
Select text to share a quote on X · sign in to keep highlights & notes in your FUM notes
Futura Medical (AIM: FUM), the consumer healthcare Group behind Eroxon® and that specialises in the development and global commercialisation of innovative and clinically proven sexual health products, announces that further to the announcement on 3 September 2026 relating to the Fundraise, it has despatched the Circular and Notice of General Meeting to Shareholders.
The Circular and Notice of General Meeting is available on the Company's website: https://futuramedical.com/investor-centre/corporate-documentation/
The Directors confirm they are to hold a General Meeting of the Company at the to be held at the offices of Panmure Liberum at Ropemaker Place, Level 12, 25 Ropemaker Street, London, England, EC2Y 9LY at 10:00 a.m. on 23 September 2026.
The results of voting on all resolutions at the General Meeting will be announced via RNS, and the full results of the voting will be published on the Company's website after the conclusion of the General Meeting.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.